The journey began with EECO2 performing an ESOS Energy Audit at the customer site. This provided a list of potential projects which would improve energy efficiency on the site.
EECO2 were then commissioned to perform a feasibility study, which showed the solutions and potential savings were feasible and could go forward and be implemented.
EECO2 focussed on the energy consumption within the warehouse and production buildings and so they were fitted with sensors to allow EECO2 to monitor the energy usage through a Mobile Energy Monitoring Unit (MEMU).
The MEMU is a unique metering solution, specifically developed to monitor the energy performance of pharmaceutical HVAC systems. It enables clients to view energy consumption and costs of individual HVAC systems on a real-time basis. The system enables a detailed view of heating, cooling and fan power energy consumption.
The agreed projects were implemented in order to reduce energy consumption, whilst maintaining quality, safety and regulatory requirements.
After the implementation of the projects, EECO2 measured the actual data of consumption via the MEMU and were able to calculate the amazing results that showed exactly what the EECO2 projects had achieved so far for the site.
EECO2 completed an outline scheme design, engineering & commercial feasibility study that determined a more accurate cost and saving estimate to implement demand-based ventilation schemes in the warehouse and production buildings.
 |
Warehouse – AHUs 1 & 2 fan utilisation and out-of-hours airflow setback |
|
Warehouse – AHU 3 essential repairs and out-of-hours setback function |
|
Production – temperature demand-controlled ventilation and out-of-hours setback |
Energy savings identified (per year):
17% reduction in site energy consumption
Energy cost savings identified (per year):
15% reduction in site energy costs
Emissions reduction (per year):
of CO2
The project had a simple payback period of 0.8 years
We can do this for you too. Speak to us today to find out what we can deliver for your business.
AbbVie
Aesica
ALKERMES
Allergan
Amgen
AstraZeneca
BAYER
Catalent
Eli Lilly
GlaxoSmithKline
Novartis
Pfizer
Pharmavite
Purogenix
Sanofi
